IamFluidics
Private Company
Total funding raised: $10.3M
Overview
IamFluidics is an innovative, award-winning company commercializing a unique microencapsulation platform that combines microfluidic-level precision with industrial scalability. Its core technology, IN-AIR MICROFLUIDICS™, uses liquid jets in mid-air to produce highly uniform microparticles, offering a gentle, solvent-free alternative to traditional methods like emulsification or spray drying. The company operates through a hybrid business model, offering encapsulation services, co-development partnerships, product sales, and equipment integration, targeting key challenges in biotherapeutics, cell therapy, and nutraceuticals. With ISO-certified pilot production capabilities, IamFluidics is positioned to translate formulation concepts into scalable, commercial-ready solutions.
Technology Platform
IN-AIR MICROFLUIDICS™: A chip-free microencapsulation platform that uses liquid jets in mid-air to produce highly uniform, monodisperse microparticles and microcapsules (30µm-3mm) with industrial-scale throughput. It is a gentle, solvent-free process suitable for sensitive materials like live cells and proteins.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
IamFluidics competes with traditional encapsulation service providers using methods like spray drying, coacervation, and emulsification, as well as other microfluidic companies (e.g., Dolomite Microfluidics, Micronit). Its key differentiator is the combination of high monodispersity (microfluidic precision) with claimed industrial scalability and gentleness for cells, a niche currently underserved by existing technologies.